Showing results (1-10 of 740) with videos related to
Sort By:
Pageof 74
Journal of Thrombosis and Haemostasis : JTH|July 10, 2023
Warfarin faring better: vitamin K antagonists beat rivaroxaban and apixaban in the INVICTUS and PROACT Xa trialsJohn W Eikelboom, Jeffrey I WeitzNature Reviews. Cardiology|March 14, 2012
Anticoagulation therapy. Dabigatran and risk of myocardial infarctionJohn W Eikelboom, Jeffrey I WeitzJournal of the American College of Cardiology|November 4, 2017
A Test in Context: D-DimerJeffrey I Weitz, James C Fredenburgh, John W EikelboomCirculation Research|April 30, 2016
Evolving Treatments for Arterial and Venous Thrombosis: Role of the Direct Oral AnticoagulantsNoel C Chan, John W Eikelboom, Jeffrey I WeitzChest|February 9, 2012
New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesJeffrey I Weitz, John W Eikelboom, Meyer Michel SamamaCirculation Research|September 18, 2012
Translational success stories: development of direct thrombin inhibitorsMichiel Coppens, John W Eikelboom, David Gustafsson, et al.JAMA Cardiology|March 30, 2017
Laboratory Monitoring of Non-Vitamin K Antagonist Oral Anticoagulant Use in Patients With Atrial Fibrillation: A ReviewJohn W Eikelboom, Daniel J Quinlan, Jack Hirsh, et al.Circulation|April 10, 2002
Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular eventsJohn W Eikelboom, Jack Hirsh, Jeffrey I Weitz, et al.Chest|February 9, 2012
Antiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesJohn W Eikelboom, Jack Hirsh, Frederick A Spencer, et al.Chest|May 1, 2015
Timing the First Postoperative Dose of Anticoagulants: Lessons Learned From Clinical TrialsJeremy S Paikin, Jack Hirsh, Noel C Chan, et al.Pageof 74